Stefanie Kreissl

Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials

Stephanie Sasse, Paul J. Bröckelmann, Helen Goergen et al. · Journal of Clinical Oncology · 2017 · 138 citations

Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group

Stefanie Kreissl, Horst Mueller, Helen Goergen et al. · The Lancet Oncology · 2016 · 113 citations

Lymphoid Neoplasia, Fatigue Management, Oncology +3

Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group

Dennis A. Eichenauer, Annette Plütschow, Stefanie Kreissl et al. · The Lancet Oncology · 2017 · 111 citations

Lymphoid Neoplasia, Medicine, Immunology +10

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration

Karolin Behringer, Helen Goergen, Horst Müller et al. · Journal of Clinical Oncology · 2016 · 93 citations

Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group

Peter Borchmann, Heinz Haverkamp, Andreas Lohri et al. · The Lancet Oncology · 2017 · 89 citations

Lymphoid Neoplasia, Progression-free Survival, Oncology +8